We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » BIO MIGHT RELAX POSITION ON GENERIC BIOLOGICS
BIO MIGHT RELAX POSITION ON GENERIC BIOLOGICS
January 11, 2005
Despite comments in a recent docket submission to the FDA that appear to indicate some softening on the topic, a representative of the trade group Biotechnology Industry Organization (BIO) says the organization is not relaxing its position on an abbreviated approval process for generic biologics.